Trial Profile
Effects of Pioglitazone on Adiponectin and Inflammatory Markers in Overweight or Obese Hemodialysis Patients: A Double-Blinded Randomized Controlled Trial
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Pioglitazone (Primary)
- Indications Insulin resistance; Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 09 Aug 2016 Status changed from recruiting to completed.
- 18 Apr 2013 Status changed from completed to recruiting as reported by ClinicalTrials.gov.
- 18 Apr 2013 Planned end date changed from 1 Jun 2013 to 1 Dec 2015 as reported by ClinicalTrials.gov.